| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 137, 4691-4698, Copyright © 1996 by Endocrine Society
ARTICLES |
B Pichon, C Jimenez-Cervantes, I Pirson, C Maenhaut and D Christophe
Institut de Recherche Interdisciplinaire en Biologie Humaine et Nucleaire, Faculte de Medecine, Universite Libra de Bruxelles, Belgique.
We investigated the induction of nerve growth factor-induced gene-B (NGFI-B) in dog thyrocytes in primary culture stimulated by different agents. The dog NGFI-B complementary DNA (cDNA) was cloned from a cDNA library of dog thyrocytes and used to study, by Northern blotting, the level of NGFI-B messenger RNA (mRNA) in those cells. We have shown that TSH and forskolin, which both induce proliferation and differentiation of the thyroid cells by activation of the protein kinase A pathway, lead to a strong and transient expression of two NGFI-B mRNA species, which differ in the length of the poly(A) tail. In contrast, 12-O- tetradecanoyl-13-phorbol-acetate (TPA) and epidermal growth factor, which induce proliferation and dedifferentiation of those cells by activation of the protein kinase C and the protein tyrosine kinase cascade, respectively, lead to a weaker expression of NGFI-B mRNA. In parallel, we studied the transactivation capacity of NGFI-B in the same cell system by transient transfection of a chloramphenicol acetyl transferase reporter construction containing a NGFI-B-dependent synthetic promoter. The highest transactivation was observed after forskolin stimulation, whereas transactivation after TPA stimulation was weak and no significant transactivation was observed after epidermal growth factor stimulation. Taken together, these results show that NGFI-B is an immediate early gene product that is mainly induced by the cAMP-dependent pathway in dog thyrocytes. Moreover they suggest that NGFI-B expression could be one of the early transcriptional changes induced specifically by this cascade and leading to differentiation and/or proliferation of these cells.
This article has been cited by other articles:
![]() |
W. C. G. van Staveren, D. W. Solis, L. Delys, D. Venet, M. Cappello, G. Andry, J. E. Dumont, F. Libert, V. Detours, and C. Maenhaut From The Cover: Gene expression in human thyrocytes and autonomous adenomas reveals suppression of negative feedbacks in tumorigenesis PNAS, January 10, 2006; 103(2): 413 - 418. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Park, K.-H. Song, H. K. Chung, H. Kim, D. W. Kim, J. H. Song, E. S. Hwang, H. S. Jung, S.-H. Park, I. Bae, et al. CR6-Interacting Factor 1 Interacts with Orphan Nuclear Receptor Nur77 and Inhibits Its Transactivation Mol. Endocrinol., January 1, 2005; 19(1): 12 - 24. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ohno, M. Zannini, O. Levy, N. Carrasco, and R. di Lauro The Paired-Domain Transcription Factor Pax8 Binds to the Upstream Enhancer of the Rat Sodium/Iodide Symporter Gene and Participates in Both Thyroid-Specific and Cyclic-AMP-Dependent Transcription Mol. Cell. Biol., March 1, 1999; 19(3): 2051 - 2060. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ortiz, M. Zannini, R. Di Lauro, and P. Santisteban Transcriptional Control of the Forkhead Thyroid Transcription Factor TTF-2 by Thyrotropin, Insulin, and Insulin-like Growth Factor I J. Biol. Chem., September 12, 1997; 272(37): 23334 - 23339. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |